News
Midodrine Cuts Recurrent Syncope in Young, Healthy Patients
Absolute risk reduced by 19 percentage points, with number needed to treat to prevent syncope of 5.3
Your search for midodrine returned 8 results
AAN 2019 Coverage
Droxidopa Associated With Better Treatment Adherence Compared With Midodrine
Droxidopa is associated with better treatment adherence than midodrine when medication cost is noninfluential.
Uncategorized
FDA proposes withdrawal of midodrine HCl
The FDA has issued a Proposal to Withdraw Marketing Approval for ProAmatine (midodrine HCl, from Shire), used in the treatment of orthostatic hypotension, because required post-approval studies that verify the clinical benefit of the drug have not been done.
Clinical Charts
Neurogenic Orthostatic Hypotension: Treatments
Treatment of Neurogenic Orthostatic Hypotension
Case Studies
A Dose of His Own Medicine Leaves Patient With a Bad Taste in His Mouth
This is only the second reported case of these rare adverse events occurring with this cardiovascular agent.
News
ProAmatine Approval and Availability Update
Shire announced that it has engaged in consistent dialogue with the FDA to secure either final FDA approval of ProAmatine (midodrine) based on the data submitted following two post-marketing clinical trials, or establish an agreed development plan for conducting additional clinical trials.
